23:29 , Oct 6, 2017 |  BioCentury  |  Finance

High as a Kite

The acquisition of Kite Pharma Inc. by Gilead Sciences Inc. turned what would have been a flattish quarter into another period of outperformance, and relieved the cash constraints that could have prevented specialists from continuing...
20:12 , Sep 22, 2017 |  BC Week In Review  |  Financial News

AbClon raises W6.8B in IPO

On Sept. 18, AbClon Inc. (KOSDAQ:174900) raised W6.8 billion ($6.1 million) through the sale of 680,741 shares at W10,000 in an IPO. Director Kyu-Tae Kim told BioCentury that AbClon's lead candidate is AC101 , a...
19:21 , Sep 19, 2017 |  BC Extra  |  Financial News

AbClon continues to rise after IPO

Korean biotech AbClon Inc. (KOSDAQ:174900) gained W4,050 (16%) to W30,050 in its second day of trading Tuesday. The closing price values the company at W204.4 billion ($183.9 million). On its first day of trading Monday,...